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Abstract The substrate specificity of protein kinase-Bcc 
(PKB~ also known as RAC kinase or Akt) was investigated 
using synthetic peptide substrates related to the sequence 
surrounding the phosphorylation site on glycogen synthase 
kinase-3 (GSK3). The minimum sequence motif required for 
efficient phosphorylation was Arg-Xaa-Arg-Yaa-Zaa-Ser/Thr- 
Hyd, where Xaa is any amino acid, Yaa and Zaa are small 
residues other than glycine and Hyd is a bulky hydrophobic 
residue (Phe, Leu). The most effective substrate, Arg-Pro-Arg- 
Thr-Ser-Ser-Phe, was phosphorylated with a Km of 5 ttM and 
ma~ of 260 U/rag. PKBcx phosphorylated histone H2B (Km 
5 ~NI, Vmax 68 U/rag) specifically at Ser-36 which also lies in an 
Arg-Xaa-Arg-Xaa-Xaa-Ser-Hyd motif. The peptide Arg-Pro- 
Arg-Ala-Ala-Thr-Phe may be a relatively specific substrate for 
PKBcx because, unlike other substrates, it is not phosphorylated 
by p70 $6 kinase or MAP kinase activated protein (MAPKAP) 
kinase-1. 
1key words." Protein kinase B; Akt or RAC kinase; Insulin; 
P[ 3-kinase; Kinase specificity; Kinase substrate; $6 kinase 
I Introduction 
Protein kinase Bot (PKBcx) [1], also known as RACot [2] and 
c Akt [3], is the cellular homologue of v-Akt, a protein en- 
c)ded in the genome of the AKT-8 acute transforming retro- 
rus isolated from a rodent T-cell lymphoma [4]. Two other 
i, oforms of PKB, termed PKB~ [5] and PKB 7 [6], have been 
i, lentified. PKBI~, also known as RAC]3 and Akt-2, is over- 
e ~pressed in a significant number of ovarian [5] and pancreatic 
['] cancers, while PKB(x is overexpressed in the breast cancer 
e ~ithelial cell line MCF7 [2]. All forms of PKB possess an N- 
t;rminal pleckstrin homology (PH) domain, followed by a 
ttalytic domain and a short C-terminal tail. The catalytic 
c omain is most similar to cyclic AMP-dependent protein ki- 
xase (PKA, 65% similarity) and to protein kinase C (PKC, 
"5% similarity), findings that gave rise to two of its names, 
x amely PKB (i.e. between PKA and PKC) and RAC (Related 
1 ) A and C kinase). 
PKBc~ is activated within 1 min following stimulation of 
tells with insulin [8,9]. The activation of PKBc~ by insulin 
, r IGF-1 is accompanied by its phosphorylation at Thr-308 
and Ser-473, and phosphorylation f both of these residues is 
required to achieve a high level of activity [10]. Like the acti- 
vation of PKB~ [11,12], the phosphorylation of Thr-308 and 
Ser-473 is prevented by wortmannin, an inhibitor of phospho- 
inositide (PI) 3-kinase [10]. 
The only physiological substrate for PKBc~ to have been 
identified to date is the protein kinase glycogen synthase ki- 
nase-3 (GSK3). GSK3 is inhibited in response to insulin with 
a half-time of 2 min, slightly slower than that for activation of 
PKBcx (1 min) and inhibition results from its phosphorylation 
at the same serine residue (Ser-21 in GSK3~ and Ser-9 in 
GSK3fi) which is targetted by PKB~x in vitro. Like the activa- 
tion of PKBc~, the inhibition of GSK3 by insulin is prevented 
by the PI 3-kinase inhibitors wortmannin and LY 294002. 
GSK3cz and GSK3[3 are phosphorylated at Ser-21 and Ser- 
9, respectively, by two other insulin-stimulated protein ki- 
nases, namely p70 $6 kinase and MAP kinase-activated pro- 
tein kinase-I (MAPKAP-KI,  also known as p90 $6 kinase). 
However, these enzymes are not rate-limiting for the inhibi- 
tion of GSK3 by insulin in L6 myotubes because specific in- 
hibitors of their activation (rapamycin-p70 $6 kinase; PD 
98059-MAPKAP kinase-1) have no effect [9]. The inhibition 
of GSK3 is thought o contribute to the stimulation of glyco- 
gen synthesis [9] and protein synthesis [13] by insulin. 
The activation of PI 3-kinase is essential for many of the 
effects of insulin and growth factors, including the stimulation 
of glucose transport, fatty acid synthesis and DNA synthesis, 
protection of cells against apoptosis and actin cytoskeletal 
rearrangements (reviewed in [14]). These observations raise 
the question of whether PKBe~ mediates any of these events 
by phosphorylating other proteins. To address this issue we 
have characterised the substrate specificity requirements of 
PKBc~. We find that the optimal consensus sequence for phos- 
phorylation by PKBcx is the motif Arg-Xaa-Arg-Yaa-Zaa-Ser/ 
Thr-Hyd, where Yaa and Zaa are small amino acids and Hyd 
is a large hydrophobic residue (Phe, Leu). We also demon- 
strate that PKBcx phosphorylates histone H2B (a substrate 
frequently used to assay PKB~ in vitro) at Ser-36 which lies 
in an Arg-Xaa-Arg-Xaa-Xaa-Ser-Hyd motif. These studies 
identified a further PKBc~ substrate (Arg-Pro-Arg-AlaoAla- 
Thr-Phe) that, unlike other peptides, is not phosphorylated 
to a significant extent by either p70 $6 kinase or MAPKAP- 
K1. 
"Corresponding author. Fax: (44) (1382) 223778• 
• ~bbreviations: PKB, protein kinase B; PI 3-kinase, phosphonositide 
.~,-kinase; MAPKAP-kinase- 1, MAP kinase activated protein kinase- 1; 
PH, pleckstrin homology; HA, haemagglutinin; PKA, cyclic AMP- 
dependent protein kinase; PKC, protein kinase C 
2. Materials and methods 
2.1. Materials 
All peptides used to assay PKBe~, and TTYADF1ASGRTGRR- 
NAIHD (the specific peptide inhibitor of cyclic AMP dependent pro- 
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tein kinase - PKI) were synthesised at Dundee on an Applied Biosys- 
tems 431A peptide synthesiser. Their purity (> 95%) was established 
by high-performance liquid chromatography and electrospray mass 
spectrometry, and their concentrations were determined by quantita- 
tive amino acid analysis. Reagents for tissue culture, myelin basic 
protein (MBP) and IGF-I were purchased from Life Technologies 
(Paisley, UK), and monoclonal antibodies recognising the haemagglu- 
tinin (HA) epitope sequence YPYDVPDYA, Protein G-Sepharose 
and histone H2B from Boehringer (Lewes, UK). MAPKAP kinase- 
11~ [15] and p70 $6 kinases [16] were purified from rabbit skeletal 
muscle and rat liver, respectively, by Dr. Nick Morrice and Sue 
Dale at the MRC Protein Phosphorylation Unit. 
2.2. Preparation and assay of PKBc~ 
The construction of cytomegalovirus vectors (pCMV5) of the hu- 
man haemagglutinin epitope-tagged wild type (HA-PKBc0 was de- 
scribed previously [10]. 293 cells grown on 10-cm dishes were trans- 
fected with a DNA construct expressing HA-PKBa using a modified 
calcium phosphate procedure [10]. The cells were deprived of serum 
for 16 h prior to lysis and, where indicated, were stimulated for 10 
min in the presence of 50 ng/ml IGF-1 to activate PKBo~. The cells 
were lysed in 1.0 ml ice-cold buffer A (50 mM Tris-HC1 pH 7.5, 1 mM 
EDTA 1 mM EGTA, 1% (by vol.) Triton X-100, 1 mM sodium 
orthovanadate, 10 mM sodium I~-glycerophosphate, 50 mM NaF, 
5 mM sodium pyrophosphate, 1 gM Microcystin-LR, 0.27 M sucrose, 
1 mM benzamidine, 0.2 mM phenylmethylsulphonyl fluoride, 10 gg/ 
ml leupeptin, and 0.1% (by vol.) 2-mercaptoethanol), thelysate cen- 
trifuged at 4°C for 10 min at 13 000 xg  and the supernatant obtained 
from one 10 cm dish of cells (2-3 mg protein) was incubated for 60 
min on a shaking platform with 20 gl of protein G-Sepharose coupled 
to 10 gg of HA monoclonal antibody. The suspension was centrifuged 
for 1 rain at 13 000 x g, the Protein G-Sepharose-antibody-HA-PKBo~ 
complex washed twice with 1.0 ml of buffer A containing 0.5 M NaCI, 
and twice with buffer B (50 mM Tris-HC1 pH 7.5, 0.1 mM EGTA, 
0.01% (by vol.) Brij 35 and 0.1% (by vol.) 2-mercaptoethanol). The 
PKBa immunoprecipitates were diluted in buffer B to an activity of 
2.0 U/ml towards the peptide GRPRTSSFAEG, termed Crosstide [9] 
and 0.1 ml aliquots snap frozen in liquid nitrogen and stored at 
-80°C. No significant loss of PKBc~ activity occurred upon thawing 
the PKBcc immunoprecipitates or during storage at -80°C for up to 
3 months. The standard PKBa assay (50 gl) contained: 50 mM Tris- 
HCI pH 7.5, 0.1 mM EGTA, 0.1% (by vol.) 2-mercaptoethanol, 2.5 
gM PKI, 0.2 U/ml PKBct, Crosstide (30 p.M), 10 mM magnesium 
acetate and 0.1 mM [y-a2p]ATP (100-200 cpm/pmol). The assays 
were carried out for 15 rain at 30°C, the assay tubes being agitated 
continuously to keep the immunoprecipitate in suspension, then ter- 
minated and analysed as described [17]. One unit of activity was that 
amount of enzyme which catalysed the phosphorylation f 1 nmol of 
Crosstide in 1 rain. The phosphorylation f other peptides, histone 
H2B and MBP was carried out in an identical manner. All the Cross- 
tide kinase activity in HA-PKBec immunoprecipitates is catalysed by 
PKBc~ (see Section 3) and the PKBc~ concentration i the immuno- 
precipitates was estimated by densitometric scanning of Coomassie 
blue-stained polyacrylamide gels, using bovine serum albumin as a 
standard. Protein concentrations were determined by the method of 
Bradford using bovine serum albumin as standard [18]. Michaelis 
constants (Kin) and Vm~, values were determined from double-recipro- 
cal plots of IlV against 11S, where V is the initial rate of phosphor- 
ylation, and S is the substrate concentration. The standard errors for 
all reported kinetic constants were within < + 20% (S.E.M.), and the 
data are reported as mean values for 3 independent determinations. 
2.3. Tryptic digestion of histone 2B phosphorylated by PKBct 
Histone H2B (30 gM) was phosphorylated with 0.2 U/ml HA- 
PKBo~. After 60 min, 0.2 vol. of 100% (by mass) trichloroacetic a id 
was added, and the sample incubated for 1 h on ice. The suspension 
was centrifuged for 10 min at 13000xg, the supernatant discarded 
and the pellet washed five times with 0.2 ml of ice-cold acetone. The 
pellet was resuspended in 0.3 ml of 50 mM Tris-HC1 pH 8.0, 0.1% (by 
vol.) reduced Triton X-100 containing 2 I.tg of alkylated trypsin and, 
after incubation for 16 h at 30°C, the digest was centrifuged for 5 min 
at 13 000 x g. The supernatant, containing 95% of the np  radioactiv- 
ity, was chromatographed on a Vydac C18 column as described in the 
legend to Fig. 2. 
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3. Results 
3.1. Preparation of protein kinase Ba 
In order to examine the substrate specificity of PKBa,  it 
was first necessary to obtain a kinase preparat ion that was not 
contaminated with any other protein kinase activities. 293 
cells were therefore transiently transfected with a DNA con- 
struct expressing haemagglutinin-tagged PKBc~ (HA-PKB~),  
stimulated with IGF-1 and the HA-PKB0t immunoprecipi-  
tated from the lysates (see Section 2). IGF-1 stimulation re- 
suited in 38-fold activation of PKBa (Fig. 1) and analysis of 
the immunoprecipitates by SDS-polyacrylamide gel electro- 
phoresis revealed that the 60 kDa PKBc~ was the major pro- 
tein staining with Coomassie Blue apart from the heavy and 
light chains of the haemagglutinin monoclonal  ant ibody (Fig. 
1, lanes 2,3). The minor contaminants were present in control 
immunoprecipitates derived from 293 cells transfected with an 
empty pCMV5 vector but lacked HA-PKB activity (Fig. 1, 
lane 4). Furthermore, a catalytically inactive mutant  HA- 
PKBa immunoprecipitated from the lysates of IGF- l -st imu-  
lated 293 cells had no Crosstide kinase activity [10]. Thus, all 
the Crosstide kinase activity in HA-PKB immunoprecipitates 
is catalysed by PKBcc 
Table 1 
Molecular basis for the substrate specificity of PKBc~ 
A Peptides K~ (gM) Vm~ (U/rag) V (0.1 raM) 
1 GRPRTSSFAEG 4 260 I00 
2 RPRTSSFA 8 305 109 
3 GRPRTSSF  8 385 129 
4 RPRTSSF 5 260 105 
5 RPRTSTF 30 243 78 
6 RPRTSAF - 0 
7 PRTSSF - 0 
8 RPRTSS > 500 ND 2 
9 KPRTSSF > 500 ND 4 
10 ~PKTSSF  > 500 ND 2 
B 
1 RPRTSSF 5 260 105 
2 RPRTSSL 8 278 104 
m 
3 RPRTSSV 21 300 102 
4 RPRTSS~ 250 265 30 
5 RPRTSS~ 80 308 67 
6 RPRTSS~ > 500 ND 9 
7 RPRTSS~A a - 0 
C 
1 RPRTSSF 5 260 105 
2 RPRASSF 12 230 89 
3 RPRQSSF 25 273 77 
4 RPR~SSF 60 163 37 
5 RPR~SSF > 500 ND 21 
6 RPR~ASF 20 213 83 
7 RPRT~SF 25 233 77 
8 RPRTVSF 30 365 89 
9 RPRT~SF 30 300 81 
10 RPRAASF 25 215 77 
I 1 RPRGGSF 105 345 55 
12 RPRGASF 105 160 37 
13 RPRAGS F 49 114 70 
The phosphorylated residue is shown in bold-face type; the altered 
residue is underlined. V (0.1 mM) is the relative rate of phosphoryla- 
tion at 0.1 mM peptide relative to peptide 1. ND, not determined. 
SAn alanine residue was added to the C-terminal of the peptide 
RPRTSSP, since we have experienced difficulty in synthesising pep- 
tides terminating in proline. 
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Lane 1 2 3 
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PKB~--III~ 
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4 
0 
+ 
m 
4" kDa 
~- -200  
- -116  
- -g7  
- -67  
~45 
H2B was digested with trypsin (see Section 2) and the result- 
ing peptides chromatographed on a Cls column at pH 1.9. 
Only one major 32p-labelled peptide (termed T1) eluting at 
19.5% acetonitrile was observed (Fig. 2A). The peptide con- 
tained phosphoserine (data not shown), its sequence com- 
menced at residue 34 of histone H2B and a single burst of 
radioactivity occurred after the third cycle of Edman degrada- 
tion (Fig. 2B), demonstrating that PKBe~ phosphorylates his- 
tone H2B at Set-36 within the sequence Arg-Ser-Arg-Lys-Glu- 
Ser-Tyr. Thus, like the serine phosphorylated in Crosstide, 
Ser-36 of histone H2B lies in an Arg-Xaa-Arg-Xaa-Xaa-Ser- 
Hyd motif (where Hyd is a bulky hydrophobic residue -Phe in 
Crosstide, Tyr in H2B). 
~IA antibody light chain r " -  
Fig. 1. Characterisation f PKBet. 293 ceils grown on l0 cm dishes 
were transiently transfected with either the pCMV5 DNA constructs 
e~,pressing wild-type PKBc~ or the empty pCMV5 cloning vector. 
Ater stimulating the cells for 10 min with 50 ng/ml IGF-l or buffer 
as a control, the cells were lysed and immunoprecipitations carried 
o~ t from each dish using the HA monoclonal antibody (Section 
2. :). Aliquots of each immunoprecipitate (2% of the sample) were 
w.ed for each assay. The activities are reported relative to those ob- 
taned for PKBt~ derived from unstimulated cells. The remainder of 
tt-e immunoprecipitate was applied to a polyacrylamide g l, which 
vv.ts then stained with Coomassie blue. The positions of the molecu- 
la  mass markers myosin (200 kDa), ]3-galactosidase (115 kDa), gly- 
c, gen phosphorylase (97 kDa), bovine serum albumin (66 kDa} and 
o albumin (43 kDa) are marked. 
3 2. Identification of the residues in histone H2B 
phosphorylated by PKBot 
Currently, three substrates are used to assay PKBe~ activity 
iz different laboratories, histone H2B, MBP and Crosstide. 
] ne last mentioned is the synthetic peptide GRPRTSSFAEG 
v:ry closely related to residues 3--13 of GSK3[3, the serine 
ulderlined (Ser-9) being the residue phosphorylated by 
P KBo~ [9]. PKBc~ phosphorylated Crosstide with a Kin of 
4 gM and a V~ .... of 260 U/mg (Table IA, peptide 1), histone 
I-!2B with a K,~, of 5 laM and a V, .... of 68 U/mg, and MBP 
ith a K,, of 5 laM and a Vm~x of 25 U/rag. Thus, the Vm~ 
~dues of histone H2B and MBP are 4- and 10-fold lower than 
f,,r Crosstide, respectively. In order to identify the residue(s) 
i~ histone H2B phosphorylated by PKBct, 32p-labelled histone 
3.3. Molecular basis for the substrate specificity of PKBo~ 
To characterise further the substrate specificity require- 
ments for PKBct, we first determined the minimum sequence 
phosphorylated efficiently by PKBc~ by removing residues e- 
quentially from the C-terminal and N-terminal end of Cross- 
tide. Removal of the N-terminal glycine and up to three res- 
idues from the C-terminus had little effect on the kinetics of 
phosphorylation by PKBct (Table 1A, compare peptides 1 and 
4). However, any further truncation of either the N- or C- 
terminus virtually abolished phosphorylation (Table IA, pep- 
tides 7 and 8). The minimum peptide phosphorylated effi- 
ciently by PKBct (Arg-Pro-Arg-Thr-Ser-Ser-Phe) was found 
to be phosphorylated exclusively at the second serine residue 
as expected (data not shown). Consistent with this finding, a 
peptide in which this serine was changed to alanine was not 
phosphorylated by PKBc¢ (Table 1A, peptide 6). All further 
studies were therefore carried out using variants of peptide 4 
in Table 1A (see below). 
A peptide in which the second serine of peptide 4 (Table 
1A) was replaced by threonine was phosphorylated with a Kn~ 
of 30 gM and an unchanged Vm~x (Table 1A, peptide 5). All 
the a2p radioactivity incorporated was present as phospho- 
threonine and solid-phase sequencing revealed that the pep- 
tide was only phosphorylated at the second threonine residue, 
as expected (data not shown). Thus, PKBct is capable of 
phosphorylating threonine as well as serine residues, but has 
a preference for serine. 
We next changed either of the two arginine residues in 
peptide 4 in Table 1A to lysine. These substitutions drastically 
decreased the rate of phosphorylation by PKBct (Table 1A, 
] tble 2 
( omparison of the substrate specificities of PKBct, MAPKAP kinase-l, and p70 $6 kinase 
Peptide Protein kinase Ba MAPKAP kinase-I p70 $6 kinase 
K,r, (gM) E .... (U/mg) Km (gM) Vm~x (U/mg) Km (gM) E .... (U/mg) 
} 
1 KKKNRTLSVA 185 270 0.2 " 1 550 ~ 3.3 a 890 ~ 
7_ KKRNRTL-qVA 80 300 0.7 ~ 1 800 ~ 1.5 ~ 1 520 ~ 
3 KKRNKT LSVA > 500 ND 17 a 840 ~ 34 ~ 760 a 
KKRNRTLTV 388 330 40" 270 a 4.8 a I 470 ~ 
t 
] GRPRTSSFAEG 4 250 2 790 3 1 270 
2 RPRTSSF 5 260 12 840 125 705 
RPRTSTF  30 240 > 500 ND 211 590 
d RPRAASF 25 215 20 1 020 > 500 ND 
5 RPRAATF 25 230 > 500 ND > 500 ND 
l'eptides I and 2 are very good substrates for MAPKAP kinase-1 and p70 $6 kinase, and peptide 3is a relatively specific substrate for p70 $6 kinase 
[' 6]. 
Data reported previously [16]; ND, not determined. 
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Fig. 2. PKBc~ phosphorylates Ser-36 of histone 2B. Histone 2B that 
had been phosphorylated with PKB~ using [7-32p]ATP (Section 2.3) 
was digested with trypsin and chromatographed on a Vydac 
218TP54 C18 column (Separations Group, Hesperia, CA) equili- 
brated with 0A% (by vol.) trifluoroacetic acid (TFA) in water. The 
column was developed with a linear acetonitrile gradient (diagonal 
line) at a flow rate of 0.8 ml/min and fractions of 0.4 ml were col- 
lected. (A) Tryptic peptide map of 32p-labelled histone H2B. 70% of 
the radioactivity applied to the column was recovered from the ma- 
jor 32p-peptide eluting at 19.5% acetonitrile. (B) A portion of the 
major 32p-peptide (50 pmol) was analysed on an Applied Biosystems 
476A sequencer, and the phenylthiohydantoin (Pth) amino acids 
identified after each cycle of Edman degradation are shown using 
the single-letter code for amino acids. A portion of the major 32p_ 
peptide (1000 cpm) was then coupled covalently to a Sequelon aryl- 
amine membrane and analysed on an Applied Biosystems 470A se- 
quencer using the modified programme described in [23]. 32p radio- 
activity was measured after each cycle of Edman degradation. 
peptides 9 and 10) demonstrating a strict requirement for 
arginine (and not simply any basic residue) at both positions. 
We then examined the effect of substituting the residues 
situated immediately C-terminal to the phosphorylated serine 
in peptide 4 (Table 1B). The data clearly demonstrate hat the 
presence of a large hydrophobic residue at this position is 
critical for efficient phosphorylation, with the Km increasing 
progressively with decreasing hydrophobicity of the residue at 
this position (Table 1B, peptides 1~,). Replacement of the C- 
terminal residue with Lys increased the Km 18-fold and a 
substitution at this position with either Glu or Pro almost 
abolished phosphorylation (Table 1B, peptides 5-7). 
Replacement of the Thr situated two residues N-terminal to 
the phosphorylated serine increased the Km with any amino 
acid tested (Table 1C). Substitution with Ala only increased 
Km by 2-3-fold, but substitution with other residues was more 
deleterious and with Asn (a residue of similar size and hydro- 
philicity to Thr) phosphorylation was almost abolished (Table 
IC). Replacement of the Ser situated one residue N-terminal 
to the phosphorylated serine also increased the Km with any 
amino acid tested, but the effects were less severe than at 
position n -2  (Table 1C). When residues n -2  and n-1  were 
both changed to Ala, the resulting peptide RPRAASF was 
phosphorylated by PKBet with a K,, only 5-fold higher than 
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that of RPRTSSF. In contrast, the peptides RPRGGSF, 
RPRAGSF, and RPRGASF were phosphorylated less effi- 
ciently (Table 1C). 
3.4. Comparison of the substrate specificity of PKB~ with 
MAPKAP kinase-1, and p70 $6 kinase 
Since MAPKAP-K1 and p70 $6 kinase phosphorylate he 
same residue in GSK3 phosphorylated by PKB~, and studies 
with synthetic peptides have established that MAPKAP-K1 
and p70 $6 kinase also preferentially phosphorylate peptides 
in which basic residues are present at positions n -3  and n -5  
[16], we compared the specificities of MAPKAP-KI ,  p70 $6 
kinase and PKBc~ in greater detail. 
MAPKAP kinase-1 and p70 $6 kinase phosphorylate he 
peptides KKKNRTLSVA and KKRNRTLSVA with ex- 
tremely low Km values of 0.2-3.3 JaM, respectively (Table 2). 
However, these peptides were phosphorylated by PKB¢~ with 
50-900-fold higher Km values (Table 2A, peptides 1 and 2). 
The peptide KKRNRTLTV, which is a relatively specific sub- 
strate for p70 $6 kinase [16] was also phosphorylated very 
poorly by PKBcc (Table 2A, peptide 4). 
Crosstide is phosphorylated by p70 $6 kinase and MAP- 
KAP kinase-1 with similar efficiency to PKB~ ([16]; Table 2B, 
peptide 1). However, truncation of Crosstide to generate the 
peptide RPRTSSF was deleterious for phosphorylation by 
MAPKAP-K1 and even worse for p70 $6 kinase (Table 2B, 
peptides t and 2). Moreover, changing the phosphorylated 
serine in RPRTSSF to threonine increased the Knx for phos- 
phorylation by p70 $6 kinase much more than for PKB~ and 
almost abolished phosphorylation by MAPKAP-K1 (Table 
2B, peptide 3). The peptide RPRAASF was phosphorylated 
by MAPKAP-K1 with essentially identical kinetics to that of 
PKB~; however, phosphorylation by p70 $6 kinase was vir- 
tually abolished (Table 2B, peptide 4). Based on these obser- 
vations we synthesized the peptide RPRAATF. This peptide 
was phosphorylated by PKBc~ with a K~ of 25 ~tM and simi- 
lar Vm~ to RPRTSSF, but was not phosphorylated to a sig- 
nificant extent by either MAPKAP-K1 or p70 $6 kinase (Ta- 
ble 2B, peptide 5). 
4. Discussion 
Many protein kinases phosphorylate serine and threonine 
residues that lie in particular amino acid sequence motifs. For 
example, PKA phosphorylates serine residues that lie in Arg- 
Arg-Xaa-Ser sequences, while casein kinase-2 phosphorylates 
serine or threonine residues that are followed by clusters of 
acidic residues [19]. In this paper, we establish that the mini- 
mum consensus equence for efficient phosphorylation by 
PKBa is Arg-Xaa-Arg-Yaa-Zaa-Ser-Hyd, where Xaa is any 
amino acid, Yaa and Zaa are small amino acid other than 
glycine (Ser, Thr, Ala) and Hyd is a bulky hydrophobic res- 
idue (Phe, Leu) (Table 1). The heptapeptide with the lowest 
Km value was RPRTSSF, its Km of 5 ~tM being comparable to 
many of the best peptide substrates identified for other protein 
kinases. The Vm~× for this peptide (260 nmol min -1 mg -1) 
may be an underestimate because the PKBc~ was obtained 
by immunoprecipitation from extracts of IGF-l-stimulated 
293 cells overexpressing this protein kinase, and a significant 
proportion of the PKBc~ may not have been activated by 
IGF-1 treatment. 
The requirement for arginine residues at positions n -3  and 
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n -5  (where n is the site of phosphorylation) is very stringent, 
because substituting either residue with lysine decreases phos- 
phorylation drastically. Serine and threonine residues were 
preferred at positions n - I  and n-2 ,  although the Km value 
w, Ls only increased about 5-fold when both of these residues 
were changed to Ala. Serine was preferred at position n, since 
changing it to threonine caused a 6-fold increase in the Kin. 
T~e peptide RPRAATF, which was phosphorylated with a 
/~, of 25 ~M and similar V, .... to RPRTSSF, may therefore 
bL a better substrate for assaying PKB~ in partially purified 
preparations, because unlike Crosstide, it contains only one 
p!tosphorylatable residue and is not phosphorylated signifi- 
cz ntly by MAPKAP-KI or p70 $6 kinase (Table 2, and see 
b, low). 
The proline at position n -4  was not altered in this study 
b,,cause it was already clear that this residue was not critical 
f lr  the specificity of PKBcc Residue n -4  is proline in GSK3[3 
b ~t alanine in GSK3cc. Both GSK3 isoforms are equally good 
st bstrates for PKBcc in vitro [9], and the peptide GRARTSS- 
1: ~ (corresponding to the sequence in GSK3c 0 is phosphoryl- 
aed  by PKBcc with a Km of 10 ~tM and V~ .... of 230 U/rag 
0ata  not shown). Moreover, in histone H2B, the residue lo- 
c. ted four amino acids N-terminal to the PKBa phosphoryla- 
ti ~n site is serine (Fig. 2). The presence of Glu and Lys at 
p )sitions n-1 and n -2  may explain why histone H2B is phos- 
p lorylated by PKBc~ with a 4-fold lower E .... than the pep- 
t~ ie RPRTSSF. 
Two other protein kinases which are activated by insulin 
a id  other growth factors, p70 $6 kinase and MAPKAP-K1, 
r~quire basic residues at positions n -3  and n -5  [16], explain- 
i~ g why they also phosphorylate and inactivate GSK3 in vitro 
[: 0]. Indeed, there is evidence that MAPKAP-KI plays a role 
i~ the inhibition of GSK3 by EGF because, unlike inhibition 
¢ insulin which is prevented by inhibitors of PI 3-kinase, the 
i~.hibition of GSK3 by EGF is only suppressed partially by 
i~hibitors of PI 3-kinase (D.A.E Cross, Y. Saito and P. Co- 
l~en, unpublished work). Moreover, in NIH 3T3 cells, the 
i:thibition of GSK3cc and GSK3[3 by EGF is largely prevented 
I: y expression of a dominant negative mutant of MAP kinase 
1, inase-I [21]. In contrast, p70 $6 kinase is not rate limiting for 
t le inhibition of GSK3 in the cells that have been examined 
s) far because rapamycin, which prevents the activation of 
t 70 $6 kinase by EGF or insulin, has no effect on the inhibi- 
t on of GSK3 by these agonists [9,22]. 
Additional similarities between p70 $6 kinase, MAPKAP- 
t,1 and PKBc~ include the failure to phosphorylate peptides 
,3ntaining Pro at position n+l and dislike of a lysine at the 
s ~me position. This suggests that, in vivo, these kinases are 
nlikely to pbosphorylate he same residues as MAP kinases 
~/hich phosphorylates Ser/Thr-Pro motifs) or protein kinase 
'. (which prefers basic residues C-terminal to the site of phos- 
1 horylation). However, the present work has also revealed 
,' ignificant differences in the specificities of these enzymes. In 
l articular, MAPKAP-K1 and (to a lesser extent) p70 $6 ki- 
J ase can tolerate substitution of the Arg at position n -5  by 
l csine whereas PKBcc cannot (see Table IA, Table 2A and 
[16]). MAPKAP-K1 and p70 $6 kinase can also tolerate, to 
,,ome extent, substitution of Arg at position n -3  by Lys. For 
txample, the peptide KKRNKTLSVA is phosphorylated by 
MAPKAP-KI and p70 $6 kinase with Km values of 17 and 34 
~,M, respectively, as compared to Km values of 0.7 and 1.5 btM 
1or the peptide KKRNRTLSVA (Table 2A). In contrast, 
PKBa does not phosphorylate the peptide KKRNKTLSVA 
(Table 2A) or any other peptide that lacks Arg at position 
n-3 .  PKBcc and p70 $6 kinase, but not MAPKAP-K1, phos- 
phorylate Thr as well as Ser (Table I A) and can phosphor- 
ylate peptides lacking any residue at position n+2 ([16] and 
Table 2A), while PKBc~ and MAPKAP-KI ,  but not p70 $6 
kinase, can tolerate substitution of both the n - I  and n -2  
positions of the peptide RPRTSSF with Ala (Table 2B). These 
differences explain why the peptide RPRAATF is a relatively 
specific substrate for PKBcc 
One of the best peptide substrates for MAPKAP-K1 and 
p70 $6 kinase (KKRNRTLSVA) was a very poor substrate 
for PKBc~ (Table 2A, peptide 2), despite the presence of Arg 
at positions n -3  and n-5 .  The presence of Leu at position 
n-1 and Val at position n+l are likely to explain the high Km 
for phosphorylation, because PKBcc prefers a small hydro- 
philic residue at the former position and a larger hydrophobic 
residue at the latter position (Tables 1 and 2). 
Finally, it is important o emphasise that GSK3 is unlikely 
to be the only physiological substrate for PKBcc The identi- 
fication of a consensus sequence for phosphorylation by 
PKBcc reported in this paper should therefore prove useful 
in pinpointing other physiological targets for this protein ki- 
nase which is likely to play important roles in mediating a
number of the intraceIlular actions of insulin, IGF-I and 
other growth factors. 
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